Similar articles

• [Progress in molecular genetics of correlating genes of breast cancer].

  Wu Y, Yang L, Wei Y. Wu Y, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Apr;19(2):152-5. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002. PMID: 11941595 Review. Chinese.
• [BRCA1 and BRCA2--breast cancer susceptibility genes].

  Dagan E, Gershoni-Baruch R. Dagan E, et al. Harefuah. 1997 Nov 16;133(10):455-7. Harefuah. 1997. PMID: 9418320 Review. Hebrew. No abstract available.
• More on breast cancer guidelines.

  Nassar BA, Ludman MD, Costa MT, Welch JP, Butts CA, Love JR, Hogg H, Beis MJ. Nassar BA, et al. CMAJ. 1998 Jun 2;158(11):1429; author reply 1429-30. CMAJ. 1998. PMID: 9629100 Free PMC article. No abstract available.
• A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.

  Ramus SJ, Friedman LS, Gayther SA, Ponder BA, Bobrow L, van der Looji M, Papp J, Olah E. Ramus SJ, et al. Nat Genet. 1997 Jan;15(1):14-5. doi: 10.1038/ng0197-14. Nat Genet. 1997. PMID: 8988162 No abstract available.
• BRCA1. A new marker in the management of patients with breast cancer?

  Offit K. Offit K. Cancer. 1996 Feb 15;77(4):599-601. doi: 10.1002/(SICI)1097-0142(19960215)77:4<599::AID-CNCR2>3.0.CO;2-C. Cancer. 1996. PMID: 8616748 No abstract available.